Frontiers The BASDAI Cut-Off for Disease Activity Corresponding to the ASDAS Scores in a Taiwanese Cohort of Ankylosing Spondylitis
Por um escritor misterioso
Descrição
Achievement of Remission Endpoints with Secukinumab Over 3 Years in Active Ankylosing Spondylitis: Pooled Analysis of Two Phase 3 Studies
Frontiers Correlation Between Chronic Pain Acceptance and Clinical Variables in Ankylosing Spondylitis and Its Prediction Role for Biologics Treatment
Evaluation of BASDAI (Panel A) and ASDAS-CRP (Panel B) during
PDF) The predictability of ASDAS on drug survival in patients with ankylosing spondylitis on biologic therapy: data from the KOBIO registry
POS0344 BASDAI CUT-OFFS FOR DISEASE ACTIVITY CORRESPONDING TO ASDAS-ESR CUT- OFFS IN AXIAL SPONDYLARTHRITIS – RESULTS FROM THE EUROSPA COLLABORATION
Frontiers Circulating Retinol-Binding Protein 4 as a Possible Biomarker of Treatment Response for Ankylosing Spondylitis: An Array-Based Comparative Study
Measures of symptoms and disease status in ankylosing spondylitis: Ankylosing Spondylitis Disease Activity Score (ASDAS), Ankylosing Spondylitis Quality of Life Scale (ASQoL), Bath Ankylosing Spondylitis Disease Activity Index ( BASDAI), Bath Ankylosing
PDF) Ankylosing spondylitis disease activity and serum vitamin D levels: A systematic review and meta-analysis
PDF) IL-17 and Disease Activity in Spondyloarthitis
de
por adulto (o preço varia de acordo com o tamanho do grupo)